Market View 17th May 2022

View on market: Stay Cautious, be with quality business:

Asian stocks rose on Tuesday amid signs of an economic slowdown due to pandemic-induced curbs, inflation, and tightening monetary settings. The Japanese markets advanced, U.S. and European futures rebounded after Wall Street logged losses on Monday. The Singapore-traded SGX Nifty, an early barometer of India’s benchmark Nifty 50, rose nearly 0.20% to 15,872 points as of 7:00 am. Commodity costs continue to climb with oil rising to $114 a barrel while Bitcoin hovered around $30,000.

Economic Calendar:

• INR: WPI Inflation on 17^thMay
• INR: RBI MPC Minutes on 18^th May 2022.
• USD: Industrial Production 18^th May, 2022.
• USD: Retail Inventory 18^th May, 2022.

Earnings Today: Bharti Airtel, DLF, Dr Lal Path Labs, Minda Corporation, Abbott India, Automotive Axles, Bajaj Electricals, EID Parry (India), EKI Energy Services, Galaxy Surfactants, GMR Infrastructure, Indoco Remedies, Indian Oil, IRB Infrastructure Developers, Jubilant Ingrevia, Kajaria Ceramics, Kirloskar Ferrous Industries, Nocil, PI Industries, Sapphire Foods India, Sun Pharma Advanced Research, Star Cement, Zydus Wellness.

Q4Fy22 Earning:

GSK Pharma: Q4 FY22 (Consolidated, YoY) Revenue up 8.76% at Rs 809.63 crore EBITDA up 11.83% at Rs 175.22 crore EBITDA margin 21.64% vs 21.05% Net profit up 8,400% at Rs 1,219.05 crore Recommended dividend of Rs 90 per share
Multi Commodity Exchange of India Q4 FY22 (Consolidated, QoQ) Revenue up 18.8% at Rs 106.46 crore EBIT up 60% at Rs 50.50 crore EBIT margin 47.44% vs 35.23% Net profit fell 5% at Rs 36.53 crore Recommended final dividend of Rs 17.4 per share

Raymond Q4 FY22 (Consolidated, YoY) Revenue up 43% at Rs 1,958.1 crore EBITDA up 84% at Rs 284.40 crore EBITDA margin 14.52% vs 11.33% Net profit up 366% at Rs 263.31 crore Recommended dividend of Rs 3 per share

PDS Q4 FY22 (Consolidated, YoY) Revenue up 57% at Rs 2,775.43 crore EBITDA up 6.2% at Rs 102.94 crore EBITDA margin 3.71% vs 5.5% Net profit up 27.87% at Rs 77.13 crore Recommended final dividend of Rs 23.85 per share

Brokerage Radar:

UBS ON BHARAT FORGE: Buy, TP Rs 900 Q4FY22 – Beat; preferred cyclical play with fx/ defense tailwinds Expect co to benefit from both domestic CV demand recovery & strong export outlook. Defense close to fruition & order can lead to significant revenue surprise.

CREDIT SUISSE ON AB CAPITAL: O-P, TP cut to Rs 130 Strong customer acquisition & retail pivot driving improvement in growth & profitability Increase FY23 EPS by 6% Retain O-P as strong growth in customer base (+46% YoY to 35 mn) is driving improvement in retail growth & profitability.

MACQUARIE ON LIC: Initiate Neutral, TP Rs 1000 Volatility in EV worries us. Large part is constituted by equity MTM gains Scaling up non-par book a challenge; our assumptions already aggressive

International Markets:

U.S. & Europe:

Asian markets:

ADR Watch:

FIIs & DII:

News Update

SJVN: The company has signed a memorandum of understanding for development of 490 MW Arun-4 project in Nepal.

Aditya Birla Capital: The company said an independent committee investigating a whistleblower complaint did not find any merit in allegations made against Aditya Birla Sun Life and its employees.

KEC International: The company has received new orders of Rs 1,147 crore across its various businesses.

Steel Exchange India: The company approved the proposal of splitting equity shares from face value of Rs 10 to Rs 1 each.

Max Healthcare Institute: Approves merger of units Alps, Max Hospitals

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL